{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:54:50Z","timestamp":1791856490451,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/bf02254221","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T17:24:31Z","timestamp":1132075471000},"page":"382-385","source":"Crossref","is-referenced-by-count":84,"title":["Invited Review Recognition and management of angiotensin converting enzyme inhibitor fetopathy"],"prefix":"10.1007","volume":"9","author":[{"given":"Aileen B.","family":"Sedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Kershaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Bunchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02254221_CR1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archinte.1994.00420050059006","volume":"154","author":"BJ Materson","year":"1994","unstructured":"Materson BJ, Preston RA (1994) Angiotensin-converting enzyme inhibitors in hypertension. Arch Intern Med 154: 513\u2013523","journal-title":"Arch Intern Med"},{"key":"BF02254221_CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1994.03510280037029","volume":"271","author":"G Viberti","year":"1994","unstructured":"Viberti G, Mogensen CE, Groop LC, Pauls JF (1994) Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes-mellitus and microalbuminuria. JAMA 271: 275\u2013279","journal-title":"JAMA"},{"key":"BF02254221_CR3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.HYP.23.3.369","volume":"23","author":"IV Yosipiv","year":"1994","unstructured":"Yosipiv IV, Dipp S, Eldahr SS (1994) Ontogeny of somatic angiotensin-converting enzyme. Hypertension 23: 369\u2013374","journal-title":"Hypertension"},{"key":"BF02254221_CR4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(80)91723-7","volume":"II","author":"F Broughton-Pipkin","year":"1980","unstructured":"Broughton-Pipkin F, Turner SR, Symonds EM (1980) Possible risk with captopril during pregnancy: some animal data. Lancet II: 1256","journal-title":"Lancet"},{"key":"BF02254221_CR5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0031-3955(16)34211-0","volume":"29","author":"JP Guignard","year":"1982","unstructured":"Guignard JP (1982) Renal function in the newborn infant. Pediatr Clin North Am 29: 777\u2013790","journal-title":"Pediatr Clin North Am"},{"key":"BF02254221_CR6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(84)90695-0","volume":"II","author":"MJ Boutroy","year":"1984","unstructured":"Boutroy MJ, Vent P, Hunault de Ligny B, Milton A (1984) Captopril administration in pregnancy impairs fetal angiotensin converting enzyme activity and neonatal adaptation. Lancet II: 935\u2013936","journal-title":"Lancet"},{"key":"BF02254221_CR7","first-page":"59","volume":"39","author":"PL Caraman","year":"1984","unstructured":"Caraman PL, Miton A, Hurualt de Ligny B, Kessler M, Boutroy MJ, Schweitzer M, Brocard O, Raggage JP, Netter P (1984) Grossesses sous captopril. Therapie 39: 59\u201362","journal-title":"Therapie"},{"key":"BF02254221_CR8","first-page":"189","volume":"4","author":"AD Rothberg","year":"1984","unstructured":"Rothberg AD, Lorenz R (1984) Can captopril cause fetal and neonatal renal failure? Pediatr Pharmacol 4: 189\u2013192","journal-title":"Pediatr Pharmacol"},{"key":"BF02254221_CR9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1113\/jphysiol.1982.sp014081","volume":"323","author":"F Broughton-Pipkin","year":"1982","unstructured":"Broughton-Pipkin F, Symonds EM, Turner SR (1982) The effect of captopril (SQ 14,225) upon mother and fetus in the chronically cannulated ewe in the pregnant rabbit. J Physiol 323: 415\u2013422","journal-title":"J Physiol"},{"key":"BF02254221_CR10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3181\/00379727-170-41446","volume":"170","author":"IM Keith","year":"1982","unstructured":"Keith IM, Will JA, Weir EK (1982) Captopril: association with fetal death and pulmonary vascular changes in the rabbit. Proc Soc Exp Biol Med 170: 378\u2013383","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF02254221_CR11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9378(94)90075-2","volume":"171","author":"WJ Harewood","year":"1994","unstructured":"Harewood WJ, Phippard AF, Duggin GG, Horvath JS, Tiller DJ (1994) Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: a prospective, placebo-controlled study in baboon (Papio Hamadryas). Am J Obstet Gynecol 171: 633\u2013642","journal-title":"Am J Obstet Gynecol"},{"key":"BF02254221_CR12","first-page":"805","volume":"60","author":"PC Duminy","year":"1981","unstructured":"Duminy PC, Burger P du T (1981) Fetal abnormality associated with the use of captopril during pregnancy. S Afr Med J 60: 805","journal-title":"S Afr Med J"},{"key":"BF02254221_CR13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1681\/ASN.V391575","volume":"3","author":"PG Pryde","year":"1993","unstructured":"Pryde PG, Sedman AB, Nugent CE, Barr M (1993) Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3: 1575\u20131582","journal-title":"J Am Soc Nephrol"},{"key":"BF02254221_CR14","first-page":"429","volume":"80","author":"JM Piper","year":"1992","unstructured":"Piper JM, Ray WA, Rosa FW (1992) Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol 80: 429\u2013432","journal-title":"Obstet Gynecol"},{"key":"BF02254221_CR15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/tera.1420440503","volume":"44","author":"M Barr","year":"1991","unstructured":"Barr M, Cohen MM (1991) ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology 44: 485\u2013495","journal-title":"Teratology"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02254221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02254221\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02254221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T21:47:06Z","timestamp":1626731226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02254221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["BF02254221"],"URL":"https:\/\/doi.org\/10.1007\/bf02254221","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}